(HBIO) Harvard Bioscience - Performance -84% in 12m
HBIO performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
-82.28%
#48 in Peer-Group
Rel. Strength
2.58%
#7224 in Stock-Universe
Total Return 12m
-84.04%
#49 in Peer-Group
Total Return 5y
-87.77%
#45 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | - |
| P/E Forward | 14.9 |
| High / Low | USD |
|---|---|
| 52 Week High | 3.54 USD |
| 52 Week Low | 0.28 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 70.14 |
| Buy/Sell Signal +-5 | -1.29 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: HBIO (-84%) vs XLV (-5.4%)
5y Drawdown (Underwater) Chart
Top Performer in Life Sciences Tools & Services
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| A NYSE Agilent Technologies |
6.27% | -6.68% | 37.4% | 29.2 | 21.2 | 1.93 | 45.2% | 4.46% |
| TMO NYSE Thermo Fisher Scientific |
2.37% | -24.9% | 12.2% | 23.8 | 17.5 | 1.51 | -28.9% | -3.66% |
| IQV NYSE IQVIA Holdings |
13.3% | -24.4% | 11.4% | 21.5 | 13.4 | 0.98 | 56.0% | 11.7% |
| RVTY NYSE Revvity |
8.28% | -5.86% | -0.14% | 39.2 | 19.3 | 0.71 | -51.9% | -36.8% |
| EKTA-B ST Elekta (publ) |
-1.85% | -22.9% | -35.5% | 77 | 12.8 | 1.32 | 16.6% | 1.38% |
Performance Comparison: HBIO vs XLV vs S&P 500
XLV (Health Care Sector SPDR ETF) is the Sector Benchmark for HBIO
| Total Return (including Dividends) | HBIO | XLV | S&P 500 |
|---|---|---|---|
| 1 Month | 9.47% | 2.04% | 4.55% |
| 3 Months | -21.59% | -7.24% | 10.78% |
| 12 Months | -84.04% | -5.41% | 14.71% |
| 5 Years | -87.77% | 43.58% | 112.53% |
| Trend Score (consistency of price movement) | HBIO | XLV | S&P 500 |
|---|---|---|---|
| 1 Month | 31.4% | 34.5% | 79.2% |
| 3 Months | 28.8% | -46.5% | 92.9% |
| 12 Months | -96.6% | -71.8% | 44.2% |
| 5 Years | -56.5% | 87.9% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XLV | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th58.82 | 7.28% | 4.71% |
| 3 Month | %th9.80 | -15.47% | -29.22% |
| 12 Month | %th5.88 | -83.12% | -86.08% |
| 5 Years | %th11.76 | -91.49% | -94.25% |
FAQs
Does Harvard Bioscience (HBIO) outperform the market?
No,
over the last 12 months HBIO made -84.04%, while its related Sector, the Health Care Sector SPDR (XLV) made -5.41%.
Over the last 3 months HBIO made -21.59%, while XLV made -7.24%.
Performance Comparison HBIO vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
HBIO vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -16.6% | 4.9% | -85% | -99% |
| US NASDAQ 100 | QQQ | -17.4% | 3.9% | -87.2% | -99% |
| German DAX 40 | DAX | -16.4% | 9.5% | -98% | -114% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -16.2% | 5.3% | -83% | -102% |
| Hongkong Hang Seng | HSI | -16.1% | 3.7% | -100.8% | -120% |
| India NIFTY 50 | INDA | -16.1% | 7.4% | -84.8% | -84% |
| Brasil Bovespa | EWZ | -17.9% | 1.7% | -109.5% | -97% |
HBIO vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | -18.1% | 2.7% | -91.7% | -113% |
| Consumer Discretionary | XLY | -15% | 7.8% | -76.3% | -104% |
| Consumer Staples | XLP | -13.1% | 11.1% | -83.2% | -93% |
| Energy | XLE | -12.2% | 6% | -79.6% | -80% |
| Financial | XLF | -16.7% | 6.4% | -88.1% | -113% |
| Health Care | XLV | -15.6% | 7.4% | -77.8% | -79% |
| Industrial | XLI | -16.2% | 5.7% | -91.6% | -108% |
| Materials | XLB | -14.6% | 7.9% | -84.4% | -87% |
| Real Estate | XLRE | -12.1% | 9.5% | -82.4% | -97% |
| Technology | XLK | -17.9% | 0.6% | -88.3% | -96% |
| Utilities | XLU | -14.1% | 9.4% | -88.4% | -108% |
| Aerospace & Defense | XAR | -18.5% | -0.4% | -106.4% | -137% |
| Biotech | XBI | -14.4% | 7.4% | -71.1% | -73% |
| Homebuilder | XHB | -14.8% | 3.4% | -73.8% | -85% |
| Retail | XRT | -13.5% | 8.1% | -76.3% | -90% |
HBIO vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | -9.3% | 4.35% | -75.7% | -74% |
| Natural Gas | UNG | -4.4% | 18.9% | -69.9% | -76% |
| Gold | GLD | -11.6% | 11.7% | -104.9% | -125% |
| Silver | SLV | -13.2% | 5.6% | -103.6% | -106% |
| Copper | CPER | -16.8% | 5.3% | -104.7% | -99% |
HBIO vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | -15.3% | 5.8% | -81.8% | -86% |
| iShares High Yield Corp. Bond | HYG | -14.5% | 7.6% | -84% | -95% |